Trials / Completed
CompletedNCT01692028
Identification of the Region of Vitamin D Responsiveness
A Novel Approach Localizes the Association of Vitamin D Status With Insulin Resistance to One Region of the 25(OH)D Continuum.
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 4,116 (actual)
- Sponsor
- Creighton University · Academic / Other
- Sex
- All
- Age
- 18 Years – 95 Years
- Healthy volunteers
- Accepted
Summary
Hypothesis: low vitamin D status is associated with increased insulin resistance and increased blood pressure. Approach: Multiple regression analysis of information extracted from a large database accumulated by a Canadian health foundation, specifically evaluating statistical associations between serum 25(OH)D levels and insulin responsiveness measures as well as blood pressure, after adjusting these variables for BMI, age, sex, and waist circumference.
Detailed description
Data obtained from the entry records of 4,116 adult men and women in Calgary,Alberta previously enrolled in the Pure North S'Energy Foundation's health program. Individuals with a clinical diagnosis of diabetes mellitus or a HOMA-IR value above 16 were excluded. Standard statistical analyses carried out. An association between 25(OH)D and the endpoints of interest was first established. The residual values after adjusting HOMA-IR, serum insulin, QUICKI, and blood pressure for BMI, age, sex, and waist circumference were then regressed against serum 25(OH)D using 40-percentile data blocks, stepping upward from the lowest 25(OH)D values by 5 percentile increments through the 7th decile. Regression coefficients are then computed for each data block and each outcome variable. The location (along the 25(OF)D continuum) of the largest and most statistically significant coefficients is noted, and regions of null response noted as well.
Conditions
Timeline
- Start date
- 2012-02-01
- Primary completion
- 2012-02-01
- Completion
- 2012-02-01
- First posted
- 2012-09-25
- Last updated
- 2012-09-25
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT01692028. Inclusion in this directory is not an endorsement.